Yubo International Biotech (YBGJ) vs. The Competition Head-To-Head Review

Risk and Volatility

Yubo International Biotech has a beta of 3.09, indicating that its stock price is 209% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s rivals have a beta of 0.92, indicating that their average stock price is 8% less volatile than the S&P 500.

Valuation & Earnings

This table compares Yubo International Biotech and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Yubo International Biotech	$610,000.00	-$1.20 million	-8.10
Yubo International Biotech Competitors	$1.01 billion	$83.13 million	10.09

Yubo International Biotech’s rivals have higher revenue and earnings than Yubo International Biotech. Yubo International Biotech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

44.3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 56.5% of Yubo International Biotech shares are owned by company insiders. Comparatively, 15.1% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Yubo International Biotech and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yubo International Biotech	-274.96%	N/A	-121.41%
Yubo International Biotech Competitors	-299.60%	-764.44%	-27.12%

Summary

Yubo International Biotech rivals beat Yubo International Biotech on 5 of the 9 factors compared.

Yubo International Biotech Company Profile

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.